Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

PLUR Relative to the S&P 500

PLUR Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Pluri Inc. (NASD:PLUR) seasonal charts above shows that a Buy Date of December 15 and a Sell Date of March 4 has resulted in a geometric average return of 15.04% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 14 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 51.94% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes?wellbeing and sustainability. The company’s technology platform?developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.

To download PLUR seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: PLUR